van Roggen J F, McMenamin M E, Fletcher C D
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Histopathology. 2001 Sep;39(3):287-97. doi: 10.1046/j.1365-2559.2001.01209.x.
To characterize the clinicopathological features and biological potential of a group of soft tissue lesions with morphology intermediate between intramuscular myxoma and low-grade myxofibrosarcoma.
Thirty-eight lesions in 37 patients were retrieved from the authors' consultation files. Clinical and follow-up data were obtained and the lesions were also studied immunohistochemically. Tumours occurred in adults aged 25-83 years (mean 51.9 years) with a slight predominance in females. All cases, except two, were solitary. The extremities were preferentially involved (18 lower limb; nine upper limb), with seven lesions arising around the upper (2/7) and lower limb (5/7) girdles and four lesions occurring at other locations. Twenty-nine of 31 of the tumours, for which the depth was known, were situated deep to the superficial fascia, although only 19 were strictly intramuscular. Histologically these lesions were both more cellular and more vascular than intramuscular myxoma, while lacking the cytological pleomorphism, nuclear atypia and curvilinear vascular pattern characteristic of low-grade myxofibrosarcoma. CD34 positivity in lesional cells was identified in 17/30 (57%) cases, probably reflecting their fibroblastic nature. Staining for alpha-smooth muscle actin was focally positive in 3/30 (10%) cases, while desmin and S100 protein staining were consistently negative. Clinical follow-up data (available in 22 cases; median duration 30 months) demonstrate that these lesions behave in a benign fashion with only a small risk of local recurrence if not excised completely; in this study only two tumours recurred, both of which originally had been incompletely excised. None metastasized.
The risk of recurrence in this group of lesions which we have designated 'cellular myxoma' appears to be low. Consequently simple complete local excision is most often adequate treatment. Longer follow-up (5-10 years or more) in a larger number of cases will be important in more definitively confirming the natural history of these lesions.
描述一组形态介于肌内黏液瘤和低级别黏液纤维肉瘤之间的软组织病变的临床病理特征及生物学潜能。
从作者的会诊档案中检索出37例患者的38个病变。获取临床及随访数据,并对病变进行免疫组织化学研究。肿瘤发生于25至83岁的成年人(平均51.9岁),女性略占优势。除2例以外,所有病例均为单发。四肢为好发部位(18例位于下肢;9例位于上肢),7个病变发生于上肢(2/7)和下肢(5/7)带周,4个病变发生于其他部位。已知深度的31个肿瘤中有29个位于浅筋膜深层,不过只有19个严格位于肌内。组织学上,这些病变比肌内黏液瘤细胞更多、血管更丰富,同时缺乏低级别黏液纤维肉瘤的细胞异型性、核异型性及曲线状血管模式。病变细胞中CD34阳性见于17/30(57%)的病例,这可能反映了它们的成纤维细胞性质。α平滑肌肌动蛋白染色在3/30(10%)的病例中呈局灶阳性,而结蛋白和S100蛋白染色始终为阴性。临床随访数据(22例可用;中位随访时间30个月)表明,这些病变表现为良性,如果未完全切除,局部复发风险较小;本研究中只有2个肿瘤复发,二者最初均为切除不完全。无一例发生转移。
我们将这组病变命名为“细胞性黏液瘤”,其复发风险似乎较低。因此,单纯完整局部切除通常是足够的治疗方法。对更多病例进行更长时间(5至10年或更长)的随访对于更确切地确认这些病变的自然病程很重要。